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PHOTOTOXICITY OF QUINOLINE METHANOLS AND OTHER
DRUGS IN MICE AND YEAST*
ARNOLD F. ISON, M.D. AND CHARLES M. DAVIS, MAJOR, USAF, MC
Many drugs and chemicals that cause adverse
photocutaneous reactions in man are photo-
toxic agents (1—6). In contrast to photoallergic
compounds (7—9), phototoxic agents would
be expected to produce reactions in a regular
predictable fashion in a model test system when-
ever sufficient drug and light are administered.
The technics of such testing have undergone
refinements and simplification in the past few
years.
Much of the early phototoxicity testing
was done on man but with new chemicals, sys-
tematic administration is often impossible and
only photopatch testing with its shortcomings
cnn be considered (1, 3, 7). A yeast cell system
(2) is useful but studies in mammals are still
necessary. The guinea pig was found respon-
sive to phototoxie reactions (4, 5) and in an
earlier study we reported that the hairless
mouse system was very sensitive and repro-
ducible (6). The relative scarcity and expense
of hairless nuce led Rothe and Jaeobus to the
observation that the exposed cars of albino mice
with hair were a suitable site to observe photo-
toxic reactions (10). The purpose of this paper
is to report results with albino mice using
known phototoxie agents and to compare the
responses with the hairless mouse and the yeast
cell systems. Also, experiments with a series of
quinoline methanols supplied by Walter Reed
Army Institute of Research Division of Medic-
inal Chemistry will be detailed. The first of the
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series, SN 10275 (6,8 dichloro 2-phenyl a-2-
peridyl 4-quinoline methanol) was found to be
not only a potent antimalarial but also a highly
active photosensitizer in man (11).
METHODs AND MATERIALS
Mouse Phototoxicity Test
The administration of the compounds and irra-
diation with the lamp were the same as previously
published (6). Swiss Webster albino mice were
used. A compound was considered phototoxic if
drug injected irradiated animals had erythema or
dermatitis of ears or tails compared to drug in-
jected non-irradiated and suspension injection ir-
radiated mice at 24 or 48 hours (Figs. 1, 2). Many
of the quinoline methanols could not be tested
above 66 milligrams per kilogram due to the small
amount of compound available.
Yeost Phototoxicity Test
This test is a modification of a technic previously
described by Daniels (2). Serial dilutions of com-
pounds to be tested were prepared using methanol.
Blank sterile paper discs (Baltimore Biological
Labs) were immersed in each dilution, removed
and allowed to air dry. Discs were placed in glass
petri dishes, on Sabouraud's agar streaked with
Candida albicans, and incubated at 30° C for 18 to
20 hours. During incubation, dishes were exposed
to a long wave ultraviolet source (General Electric
F4OBLB). Other petri dishes prepared and han-
dled in a similar manner but kept in darkness
served as controls. A dilution was considered pho-
totoxie when a zone of inhibited yeast growth
around the irradiated disc was greater than that
around the control disc. Experiments were re-
peated at least 3 times and the lowest concentra-
tion of drug showing phototoxieity was recorded
as the minimal phototoxic concentration (MPC).
If no phototoxicity was demonstrated at several
thousand milligrams per liter, experiments were
repeated by placing the pure chemical directly on
the inoculated test agar.
RESULTS
In the mouse system phototoxieity was dem-
onstrated with 8-methoxypsoralen, eblorprom-
azine, proehlorperazine, demethylchlortetracy-
dine, tetracycline, chlordiazepoxide, and the
quinoline methanol SN 10275 (Table I). No
phototoxicity was elicited with chlorothiazide,
tolbutamide, griseofulvin, or tribromsalieylan-
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Fia. 1. Phototoxie reaction in Swiss Webster albino mice. The animal on the right shows
a phototoxic response with erythema, venous distention and edema of the ears. Irradiated
control is on the left.
and tetracycline which were not phototoxie to
yeast. In the mouse tests less demethylehlor-
tetracycline was required than tetracycline to
induce a photosensitive reaction and less chlor-
promazine than prochlorperazine was needed in
both systems. No phototoxicity was elicited
with quinaerine in the yeast test.
Of the 81 quinoline methanols evaluated, 62
were phototoxic using at least one of the tests.
Quantitative results with data ranked either
by the yeast or the mouse test are shown in
Tables III and IV. The more active compounds
in mice tended to be the most active in yeast
but a number of exceptions were noted. Al-
though phototoxicity was seen with all com-
binations of molecular substitution, the greatest
number were found when substitutions were at
positions 1L or 118 on the quinoline methanol
molecule (Fig.3).
DISCUSSION
FIG. 2. A severe phototoxic reaction several
weeks after irradiation. There is loss of ears, nb-
pecia, crusting, and permanent changes of the skin
along with damage of the eyes and blindness.
ilide (Table II). The dose at which photo-
toxicity was seen in 50% of animals tested
(PTD8O) was calculated (12) (Table I). The
results were similar using the yeast cell test
with the exception of demethylehlortetracycline
Results of experiments with hairless and
ordinary albino mice correlate closely, indicat-
ing that the cheaper, most easily obtainable
hairy mouse can be used as an alternative ex-
perimental animal (Table I). Except for quin-
acrine, yeast test results correlate with studies
previously published (2). Phototoxicity was
elicited with most of the known photasensitiz-
ers. Although phototoxicity was not seen with
chborothiazide in these experiments, it has been
demonstrated in animals using natural sun-
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TABLE I
Phototoxicity results using known photosensilizers
Drug
Albino mice Hairless albino juice5 Yeast
, No. of
animals tested"
e° No. ofanimals tested"
SN 10275
8-methoxypsoralen
Chlorpromazine
Prochiorperazine
Demethyichiortetracycline
Tetracycline
Chlordiazepoxide
7
18
18
25
59
176
80
8
14
17
35
14
28
14
13 10
20 10
20 16
46 11
50 12
155 20
Not done
31
3.2
1,250
2,000
No phototoxicity
No phototoxicity
8,000
Results previously reported (6).
Mgm/kg dose at which 50% of animals developed a phototoxic reaction.
"Excluding controls.
Minimal phototoxic concentration in mgm/L.
TABLE II
Failure to demonstrate phototoxicity using known photosensitizers
Drug
Albino mice Hairless albino mice5 Yeast
Maximum dose
(mgm/kg)5
No. of
animals tested"
Maximum dose No. of
(mgm/kg)' animals tested"
Maximum concentration
(mgm/L)'
Tribromosalicylanilide
Chiorothiazide
Toihutamide
Griseofulvin
33
660
660
660
4
4
4
4
33 14
660 12
660 4
Not done
10,000
2,800
30,000
Undilutedd
Results previously reported (6).
Higher concentrations were lethal.
Excluding controls.
d Pure powder applied directly to yeast plates.
light and filters that exclude short wave ultra-
violet light (5, 6). No phototoxicity was demon-
strated with tribromsalicylanilide, presumably
because it is a photoallergen (8, 9). Most of
the quinoline methanols were phototoxic in one
or both of the test systems; however, occasion-
ally they were positive in one and negative in
the other. The significance of these differences
and the predictive value of the two test sys-
tems will not be resolved until clinical experi-
ence has been obtained.
Only longwave ultraviolet light was necessary
to produce positive results since window glass
which excludes wavelengths below 315 nanom-
eters was used as a filter. This correlates with
previous findings in this laboratory, and those
of others (1, 4, 5, 13, 14). Excluding erythe-
mogenic short wave ultraviolet light allows clear
and unequivocal end points to be determined
in animals, and minimizes false positive tests
(6).
SUMMARY
Reactions to phototoxic drugs such as 8-meth-
oxypsoralen, phenothiazines, tetracyclines, and
chlordiazepoxide can be induced in albino mice
or in yeast cells with longvave ultraviolet
light. The relationship of the doses required to
produce reactions with known human photo-
sensitizers parallels those in man and closely
corresponds to those in hairless mice. Ordinary
albino mice therefore are suitable experimental
animals for phototoxicity studies. Of 81 related
quinoline methanols tested in the mouse and
yeast systems, 62 were phototoxic. The signifi-
cance of discrepancies between the two test
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TABLE III
Reactive compounds ranked by results in mice with yeast data
5-Br-2-thienyl
4-Ci-phenyl
4-Ci-phenyl
4-OCil4-phenyl
4-CL-phenyl
4-Cil3-phenyl
4-F-phenyl
4-F-phenyl
4-Ci-phanyl
4'-Cl-phenyl
3 ,4-diCl-phenyl
4'F-phenyl
3',4'-diCl phertyl
3 ,4-diO Gil 3phenyl
4-Gils-phenyl
4-Cils-phenyl
4'-Cl-phanyl
Phenyl
4'-F-phenyl
4'-Cl-phenyl
4'-F-phenyl
3' ,4'-diCl phenyl
4-OCils-phenyl
3,4 di-OCH3-phenyl
4'-Cl-phenyl
4'-Cl-phenyl
4-Ci-phenyl
4-OCH3-pheriyl
4-Ci-phenyl
4'-F-phenyl
4-OCil3-phenyl
4'-Cl-phenyl
3 ,4-methylene-
dioxyphenyl
4'-Cl-phenyl
3 ,4-diCl-phenyl
4'-Cl-phenyl
4-Gil3-phenyl
phenyl
3' ,4'-diCl-phenyl
4'-Cl-phenyl
4'-Cl-phenyl
3' ,4'-diCl-phenyl
€iilO
Gil5
Cil30
CH3O
C'
CI
C'
CH30
C'
C'
CU3
CF3
CF3
Gil3
Gil3
Gil3
Gil3
C'
C'
Cil3
Cl
C'
CF3
Gil3
C'
N-Cils-N-benzylmethyl
5-dimethylamino-2 hydroxy-2-
pentyl-2-methyl
2-piperidyl
2-piperidyl
2-piperidyl
2-piperidyl
2-piperidyl
2-piparidyl
butylamiuomathyl
di-N-butylaminomethyl
bis-2-ethoxy-ethylaminomethyl
di-N-butylaminomathyl
di-dibutylaminomethyl
dibutylaminomethyl
2-piperidyl
diethyl-amissomethyl
4-methyl-1-piperazinylmethyl
2-piparidyl
4-methyl-1-piperazinylmethyl
di-N-butylaminomethyl
di-N-butylaminomethyl
benaylaminomethyl
2-piperidyl
diethylaminomethyl
4-phanyl-1-piperazinylmathyl
4-rnathyl-l-piperazinylmethyl
4-methyl-1-piperazinylmethyl
dibutylaminomethyl
di-N-butylaminomethyl
4-phenyl-1-piperazinylmethyl
dibutylaminomethyl
di-isopentylaminomethyl
dibutylaminomethyl
di-N-haxylaminomethyl
dihexylaminomethyl
4-phenyl-1-piperazinylmethyl
di-N-butylaminomethyl
morpholinomethyl
di-N-butylaminomethyl
bromomethyl
di-N-hexylaminomethyl
di-N-butylaminomethyl
R2 F., R, F., F.' MicePTD,0
Yeast
MPCf
Gil3
Cil3
Gil3
Cl
Cl
Cl
Cl
Cl
F
Cl
CI
F
CF3
Cl
Cl
F
Cl
Cl
Cl
Cil30
CF3
Gil3
Gil3
Gil3
Cl
CI
Cl
Cl
Cl
2
2
3.3
3.3
S
5
5
5
5
5
5
5
6.6
6.6
20
20
20
20
20
20
20
33
33
33
33
40
40
40
40
40
66
66
66
66
66
66
360
360
360
360
360
360
31
63
31
61
31
60
63
63
63
125
250
1,000
160
250
31
63
125
250
250
1,000
Neg.
250
1,000
1,000
Neg.
31
31
125
500
Neg.
128
250
250
375
500
Neg.
125
160
25
500
500
500
C'
Gil3
Cl
Cl
Gil3
Cl
* Positive phototoxia dose in 50% of animals.
Minimum phototoxia concentration.
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TABLE IV
Nonreactive compounds in mice ranked by phototoxicity in yeast
R3 Rs R7 R, R' Mice MDT' Yeast MPCf
3 ,4-diCl-phenyl OCH3 diethylaminomethylbutyl- 66 31
aminomethyl
4-Ci-phenyl CH3 2-piperidyl 66 70
4-F-phenyl CH3 2-pyridyl 66 125
4-CI-phenyl OCH3 Cl di-N-hexylaminomethyl 66 125
phenyl CH3 2-pyridyl 66 250
3,4-diCi-phenyl OCH3 dibutylaminomethyl 66 250
4-OCH3-phenyl Cl Cl dihexylaminomethyl 66 250
4-00H3-phenyl Cl OCH3 dibutylaminomethyl 66 250
4-F-phenyl F morpholinomethyl 66 500
phenyl Cl Cl di-N-hexylaminomethyl 66 1,000
3 ,4-diCl-phenyl OCH3 dioctylaminomethyl 66 1,000
4'-F-phenyl F 2-piperidino-methyl 66 1,000
3'-CH3-phenyl Cl Cl di-N-butylaminomethyl 66 1,000
phenyl methyl, 7-dimethylamino- 66 1,000
pentyl
4'-Cl-phenyl CF3 di-N-hexylaminomethyl 66 1,000
CF3 C113 2-piperidyl 66 1,000
4-Ci-phenyl Cl OCH3 dibutylaminomethyl 66 1,000—2,000
phenyl 2-piperidyl 66 3,300
3,4-diOCH3-phenyl Cl dihexylaminomethyl 66 4,000
phenyl methylsulfinylme thy! 66 4,000
phenyl CH3 2-piperidyl 66 pos. AS
powder
phenyl CF3 methyl, phenyl 66 neg.
phenyl CF3 2-pyridyl 66 neg.
phenyl CH3 Cl3 2-pyridyl 66 neg.
CF3 CH3O 2-piperidyl 66 neg.
CF3 C1130 2-pyridyl 66 neg.
CF3 2-piperidyl 66 neg.
CF3 2-pyridyl 66 neg.
CF3 CH3 2-pyridyl 66 neg.
CF3 CH3 CH3 2-pyridyl 66 neg.
4-CH3-phenyl CH3 2-pyridyl 66 neg.
CF3 CH3 2-piperidyl 66 neg.
CF3 Cl 2-piperidyl 66 neg.
C(CH3)3 Cl 2-piperidyl 66 neg.
C(CH3)3 2-piperidyl 66 neg.
C(CH3)3 2-pyridyl 66 neg.
3'4'-diCl-pheriyl Cl Cl di-N-butylaminomethyl 660 10,000
CF3 CH3 2-pyridyl 660 neg.
CF3 Cl 2-pyridyl 660 neg.
* Maximum dose tested.
t Minimum phototoxic concentration.
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CHOH—R1
systems will be resolved only after use of the
drugs in man.
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